Remove Packaging Remove Vaccines Remove White Paper
article thumbnail

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. GSK has licensed altSonflex1-2-3, its Shigella vaccine candidate, to Bharat Biotech for continued development and distribution in low and middle-income nations. Credit: viewimage/Shutterstock.

article thumbnail

DoH – Abu Dhabi and Sanofi link for vaccine development

Pharmaceutical Technology

The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a memorandum of understanding (MoU) to bolster vaccine development by leveraging local health-tech ecosystems and research infrastructure. Credit: Department of Health Abu Dhabi.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Madrigal poised to enter European MASH market after CHMP endorsement

Pharmaceutical Technology

Give your business an edge with our leading industry insights.

article thumbnail

NSW government invests $13.39m in life-changing therapies

Pharmaceutical Technology

Give your business an edge with our leading industry insights.

article thumbnail

London Biotechnology Show 2025: Novo Nordisk harnesses AI/ML to accelerate drug development landscape

Pharmaceutical Technology

Give your business an edge with our leading industry insights.

article thumbnail

Outlook’s wet AMD treatment accepted by SMC for NHS Scotland

Pharmaceutical Technology

Give your business an edge with our leading industry insights.

article thumbnail

Antares Therapeutics gains $177m for cancer medicines development

Pharmaceutical Technology

Give your business an edge with our leading industry insights.